Enliven Therapeutics, Inc. Quarterly Operating Lease, Payments in USD from Q2 2019 to Q1 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
Enliven Therapeutics, Inc. quarterly/annual Operating Lease, Payments history and growth rate from Q2 2019 to Q1 2022.
  • Enliven Therapeutics, Inc. Operating Lease, Payments for the quarter ending March 31, 2022 was $69K, a 1.47% increase year-over-year.
Operating Lease, Payments, Quarterly (USD)
Operating Lease, Payments, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2022 $69K +$1K +1.47% Mar 31, 2022 10-Q 2022-05-06
Q1 2021 $68K Mar 31, 2021 10-Q 2021-05-11
Q2 2019 $300K May 31, 2019 10-Q 2021-05-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.